financetom
UG
financetom
/
Consumer Staples
/
UG
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
United-Guardian, Inc.UG
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products.

The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology.

Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser.

The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

Latest News >
Exchange-Traded Funds, US Equities Advance After Midday Friday
Exchange-Traded Funds, US Equities Advance After Midday Friday
Apr 11, 2025
01:11 PM EDT, 04/11/2025 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV rose. Actively traded Invesco QQQ Trust (QQQ) added 1.3%. US equity indexes rose in choppy midday trading Friday amid continuing sharp declines in government bond prices and the dollar as producer prices eased and the trade war with China intensified. Energy IShares US Energy...
UBS on Canadian Grocers Q1 Preview
UBS on Canadian Grocers Q1 Preview
Apr 11, 2025
01:00 PM EDT, 04/11/2025 (MT Newswires) -- Canadian grocers were navigating a challenging backdrop in the first quarter, notes UBS. The tariff situation is adding to an already soft consumer confidence environment. The loonie was also down ~6% relative to the greenback, impacting consumer purchasing power. Still, there were some glimmers of improvement. Statistics Canada's Food & Beverage Store Retail...
US oil rig count falls by most in a week since June 2023, Baker Hughes says
US oil rig count falls by most in a week since June 2023, Baker Hughes says
Apr 11, 2025
April 11 (Reuters) - U.S. energy firms this week cut oil rigs by the most in a week since June 2023, lowering the total oil and natural gas rig count for a third consecutive week, energy services firm Baker Hughes ( BKR ) said in its closely followed report on Friday. The oil and gas rig count, an early indicator...
BioCardia Says Emory University Enrolling Heart Patients for CardiAMP HF II Trial
BioCardia Says Emory University Enrolling Heart Patients for CardiAMP HF II Trial
Apr 11, 2025
01:03 PM EDT, 04/11/2025 (MT Newswires) -- BioCardia ( BCDA ) said Friday that Emory University School of Medicine in Atlanta has started enrolling patients with ischemic heart failure in the company's ongoing phase 3 CardiAMP HF II trial. The CardiAMP HF II therapy is a system designed for the harvest, processing and minimally invasive delivery of autologous mononuclear cells...
Copyright 2023-2026 - www.financetom.com All Rights Reserved